生物钟基因Per2抑制人骨肉瘤细胞生长的实验研究
[Abstract]:Background osteosarcoma is the most common primary malignant tumor originating in the osteogenic mesoleaf tissue. It is found in children and adolescents. The 20%., which accounts for all bone tumors, is currently significantly controlled by early diagnosis and rapid development of chemotherapy. The 5 year survival rate has increased by more than 50%, but it is about 30%. More than half of the patients died of metastasis and recurrence of osteosarcoma, and the treatment of osteosarcoma was in a platform period. In recent years, especially since twenty-first Century, the basic research on the mechanism of osteosarcoma caused by medical scientists and technicians has been improved by the continuous improvement of the theory and technology level in the field of molecular biology. The understanding has reached an unprecedented level at the molecular level, looking forward to a breakthrough in the pathogenesis of osteosarcoma and the research of gene therapy. The physiological, biochemical and behavioral processes of various organisms show certain circadian rhythms. The circadian clock can be considered as a timing system in the body because of its existence. A variety of physiological activities in the body, the behavior pattern can show the regular rhythm of the approximate 24h, and thus make adaptive response to the periodic environment of its existence. Biological rhythm is one of the basic characteristics of life activities, not only in the whole body, but also in the organs, tissues, and free individual cells. The basic structure that maintains these rhythms is the circadian clock, and the molecular biological basis for the production and maintenance of biological rhythms is the biological clock gene (circadian clock genes). Up to now, at least 10 kinds of biological clock genes have been found in mammals. The substance basis of the circadian rhythm is called the biological basis. A biological oscillator (oscillator) is made up of a series of rhythmic clock genes and their corresponding protein products as a specific core component. The biological rhythm of the transcriptional translation feedback loop, composed of these specific core components, is the basic molecular mechanism. The clock gene is a timing controller for life activities. From the microcosmic aspect of the body, the growth, development, disease and decay of the body are controlled, and the relationship between the cell proliferation cycle, cell apoptosis, neuroendocrine and immune function is closely related to the occurrence, development, treatment and prognosis of malignant tumor. The Per2 gene in the Period family of biological clock gene is one of the important biological clock genes. It exists in the central system of the body, peripheral tissue and tumor cells. Besides its biological cycle rhythm regulation function, it also has the non rhythmic function that plays an important role in the development of malignant tumor. The abnormal expression of Per2 can be detected in breast, prostate and gastric cancer, but the role of Per2 in human osteosarcoma has not yet been reported. Therefore, further study on the pathogenesis of osteosarcoma will be helpful to explore a new method for diagnosis and treatment of bone tumor, and to determine the prognosis and prognosis. The expression of pEGFP-N1-hPer2 eukaryotic expression vector was identified and its expression in osteosarcoma cell MG63 was observed. The effect of hPer2 on human osteosarcoma cell MG63 and its mechanism were investigated by the cell level in vitro. Method (1) hPer2 was amplified from MG63 cells by RT-PCR technology, and the product of PCR was cloned into pEGFP-N1 by double enzyme digestion. The recombinant plasmid of hPer2 was identified by double enzyme digestion and sequencing, and the eukaryotic expression vector of pEGFP-N1-hPer2 was successfully constructed. (2) the expression of hPer2 was detected by liposome mediated transfection of osteosarcoma cells MG63, qRT-PCR and Western blot respectively. (3) the eukaryotic expression plasmid pEGFP-N1-hPer2 and empty plasmid pEGFP-N1 were transferred by liposome method respectively. MG63 was injected into MG63, divided into pEGFP-N1-hPer2 transfection group, pEGFP-N1 empty plasmid transfection group and blank group without any treatment. RT-PCR and Western blot were used to detect the expression of Per2 gene and protein, CCK-8, flow cytometry and Transwell cell method were used to detect cell proliferation, apoptosis, periodic distribution and invasion ability. Results (1) recombinant plasmid The particle pEGFP-N1-hPer2 was cut and sequenced by Pst I, Kpn I and sequencing with the hPer2 gene sequence. (2) the pEGFP-N1-hPer2 recombinant plasmid was successfully transfected into the osteosarcoma cell MG63 by liposome mediated and the overexpression of the hPer2 gene was obtained. (3) compared with the control group and the blank group, the test group was able to proliferate the tumor cells through the over expression of hPer2. Conclusion the pEGFP-N1-hPer2 eukaryotic expression vector can be successfully constructed and the overexpression of.HPer2 in osteosarcoma cell MG63 can inhibit its growth in human osteosarcoma cell line MG63. Therefore, the biological clock gene hPer2 can be used as a possible method of gene therapy for human osteosarcoma. One of.
【学位授予单位】:武汉大学
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R738.1
【相似文献】
相关期刊论文 前10条
1 薛华明;人骨肉瘤细胞在单层及三维培养中的代谢水平变化[J];国外医学.骨科学分册;2004年03期
2 易成腊;李新志;徐卫国;陈安民;;肿瘤转移相关基因1在人骨肉瘤细胞的表达与转移侵袭的关系[J];中华实验外科杂志;2006年04期
3 郑强,范清宇;白细胞介素-2基因转染人骨肉瘤细胞的体外生物学特性[J];第四军医大学学报;1999年02期
4 宝建中,陶文照,肖辉,倪灿荣;裸小鼠人骨肉瘤细胞移植瘤株建立及其特性观察[J];肿瘤;1993年02期
5 刘光,高奉浔,王东,冯素珍;人骨肉瘤细胞浸润转移相关表型的研究[J];第三军医大学学报;1997年06期
6 王洪,杜靖远,罗怀灿,刘国平;人骨肉瘤细胞体外药物敏感性的实验研究[J];同济医科大学学报;1998年02期
7 潘朝晖,范清宇,殷剑宁,蒋维中,张殿中;裸小鼠原位移植筛选高转移性人骨肉瘤细胞系及其生物学特性分析[J];细胞与分子免疫学杂志;2000年03期
8 楼列名;吴兴;顾昕;刘珊林;;锰型超氧化物歧化酶基因转染对人骨肉瘤细胞的诱导凋亡作用[J];上海医学;2007年06期
9 李星星;何焕玲;吴丽美;左国伟;苗静琨;周兰;;人骨形态发生蛋白12对人骨肉瘤细胞的生物学作用[J];生命科学研究;2008年04期
10 吴进;杨彤涛;甘璐;周勇;;电压门控性钾离子通道对人骨肉瘤细胞增殖的影响[J];科学技术与工程;2009年16期
相关会议论文 前5条
1 辛曾峰;郑强;;藤黄酸抑制人骨肉瘤细胞系侵袭性的体外研究[A];2012年浙江省骨科学术年会论文集[C];2012年
2 宝建中;陶文照;肖辉;倪灿荣;;裸小鼠人骨肉瘤细胞移植模型的建立及其特性观察[A];中国细胞生物学学会第五次会议论文摘要汇编[C];1992年
3 杨彤涛;张勇;李存孝;黄立军;周勇;范清宇;马保安;;反义RNA抑制Survivin在人骨肉瘤细胞系MG63中表达的实验研究[A];全国骨科临床研究新进展研讨会暨学习班论文集[C];2006年
4 何焕玲;左国伟;赖天霞;王嫣;陈小菊;李星星;苗静琨;谭启华;寇小琴;周兰;;骨形态发生蛋白-2和-6对人骨肉瘤细胞U2OS作用的研究[A];第四届中国肿瘤学术大会暨第五届海峡两岸肿瘤学术会议论文集[C];2006年
5 熊文化;庞清江;杨长春;袁欣华;陈晓牛;;PIN1反义基因转染抑制人骨肉瘤细胞的增殖[A];2006年浙江省骨科学术会议暨浙江省脊柱脊髓学术会议论文汇编[C];2006年
相关博士学位论文 前10条
1 程安源;生物钟基因Per2抑制人骨肉瘤细胞生长的实验研究[D];武汉大学;2016年
2 郑强;白细胞介素-2真核表达载体的构建及其在人骨肉瘤细胞系内的表达的实验研究[D];第四军医大学;1998年
3 曹东;pcDNA3.1/his-Noggin真核表达载体抑制人骨肉瘤细胞增殖性的实验研究[D];第二军医大学;2008年
4 张海英;SATB1在维持人骨肉瘤细胞生物学行为中的作用及其分子机制的研究[D];吉林大学;2013年
5 李丁;姜黄素对人骨肉瘤细胞放射增敏作用的实验研究[D];中南大学;2012年
6 刘艳武;紫檀芪通过抑制JAK2/STAT3信号通路抗人骨肉瘤细胞活性研究[D];第四军医大学;2013年
7 崔俊成;核仁素反义寡核苷酸对人骨肉瘤细胞MG-63抑制作用的实验研究[D];中南大学;2012年
8 李存孝;CD147在人骨肉瘤细胞中的表达及其反义RNA对骨肉瘤侵袭和转移的影响[D];第四军医大学;2005年
9 仲苓芝;H0-1在维持人骨肉瘤细胞对三氧化二砷抗性中的作用及分子机制研究[D];吉林大学;2014年
10 曲珊珊;HMGA2在维持人骨肉瘤细胞恶性表型中的关键作用及分子机制研究[D];吉林大学;2010年
相关硕士学位论文 前10条
1 刘力;IGF-1R抑制剂PPP对人骨肉瘤细胞U-2OS的影响及其机制的研究[D];暨南大学;2015年
2 何凯元;过表达CADM1对人骨肉瘤细胞U-2 OS的影响及其与ERK5信号通路的关系[D];暨南大学;2015年
3 燕明;极低频电磁场对人骨肉瘤细胞的体外生物效应研究[D];第四军医大学;2015年
4 孟子钧;吴茱萸碱抑制人骨肉瘤细胞143B增殖与PI3K/Akt信号关系的研究[D];重庆医科大学;2015年
5 张汝益;miR-30a通过下调Runx2抑制人骨肉瘤细胞的迁移,侵袭和增殖[D];重庆医科大学;2015年
6 姚娟;NOV的差异表达对人骨肉瘤细胞系增殖、凋亡和迁移的影响及机制研究[D];重庆医科大学;2016年
7 仇超;Id1基因对人骨肉瘤细胞MG63恶性逆转向成骨分化的影响及作用机制[D];重庆医科大学;2016年
8 周云飞;HELQ激活CHK1-RAD51信号通路抑制人骨肉瘤细胞恶性表型[D];南昌大学;2016年
9 吴进;人骨肉瘤细胞与电压门控性钾离子通道关系的研究[D];第四军医大学;2009年
10 李天强;免疫球蛋白重链结合蛋白在人骨肉瘤细胞中的表达及临床意义[D];山东中医药大学;2010年
,本文编号:2141058
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2141058.html